Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists.

@article{Guitton2018RiskOT,
  title={Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists.},
  author={Zelie Guitton and Louis Terriou and J. C. Lega and Raphaele Nove-Josserand and Miguel Hi{\'e} and Zahir Amoura and James B Bussel and Mohamed Amine Hamidou and Eric Rosenthal and Bertrand Lioger and Dominique Chauveau and Axel Chaminade and Nadine Magy-Bertrand and Marc Michel and Sylvain Audia and Bertrand Godeau and Matthieu Mah{\'e}vas},
  journal={Rheumatology},
  year={2018},
  volume={57 8},
  pages={
          1432-1438
        }
}
Objectives The use of thrombopoietin-receptor agonists (TPO-RAs) has increased as a second-line therapy in ITP, but the efficacy and safety of such drugs has not been evaluated in SLE-associated ITP. Methods This was a multicentre retrospective cohort study from 2009 to 2016. Participating centres (n = 11) were secondary- or tertiary-care hospitals belonging to the French national network for adult ITP. Results We included 18 patients with SLE-ITP treated with TPO-RAs; 10 (55%) had aPL, 5… CONTINUE READING
11
Twitter Mentions

Citations

Publications citing this paper.
SHOWING 1-2 OF 2 CITATIONS

DOES THE PRESENCE OF THROMBOCYTOPENIA IN A PATIENT WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME PREDICT THE EVENTUAL EMERGENCE OF SYSTEMIC LUPUS ERYTHEMATOSUS ?

Andrew P. Vreede, Paula L. Bockenstedt, W. Joseph McCune, Jason S. Knight
  • 2019

References

Publications referenced by this paper.
SHOWING 1-10 OF 39 REFERENCES

Rituximab be useful for treating SLE - associated immune cytopenias ? Results from a Retrospective Multicentre Study on 71 patients in San Diego

AC Serris
  • 2016

Rituximab be useful for treating SLE-associated immune cytopenias? Results from a Retrospective Multicentre Study on 71 patients

AC Serris
  • in San Diego. 2016 [cited
  • 2016

The diagnosis and management of the haematologic manifestations of lupus

A Velo-Garcı́a, SG Castro, DA. Isenberg
  • J Autoimmun
  • 2016